
Michael J. Feely
Examiner (ID: 17056, Phone: (571)272-1086 , Office: P/1766 )
| Most Active Art Unit | 1766 |
| Art Unit(s) | 1712, 1741, 1761, 1796, 1766 |
| Total Applications | 1914 |
| Issued Applications | 1375 |
| Pending Applications | 116 |
| Abandoned Applications | 442 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19612263
[patent_doc_number] => 20240397943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-05
[patent_title] => COMPOSITIONS AND METHODS TO MANAGE HEMIPTERA
[patent_app_type] => utility
[patent_app_number] => 18/802938
[patent_app_country] => US
[patent_app_date] => 2024-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1756
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18802938
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/802938 | COMPOSITIONS AND METHODS TO MANAGE HEMIPTERA | Aug 12, 2024 | Pending |
Array
(
[id] => 20007412
[patent_doc_number] => 20250145634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-08
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 18/741322
[patent_app_country] => US
[patent_app_date] => 2024-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41802
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18741322
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/741322 | COMPOSITIONS AND METHODS FOR TREATING CANCER | Jun 11, 2024 | Pending |
Array
(
[id] => 19403519
[patent_doc_number] => 20240287030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => PROCESS FOR PREPARING 6-SUBSTITUTED-1-(2H)-ISOQUINOLINONES AND INTERMEDIATE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 18/636763
[patent_app_country] => US
[patent_app_date] => 2024-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28028
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18636763
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/636763 | Process for preparing 6-substituted-1-(2H)-isoquinolinones and intermediate compound | Apr 15, 2024 | Issued |
Array
(
[id] => 19345177
[patent_doc_number] => 20240254140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => COMPOUNDS AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTION
[patent_app_type] => utility
[patent_app_number] => 18/609825
[patent_app_country] => US
[patent_app_date] => 2024-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24165
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18609825
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/609825 | COMPOUNDS AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTION | Mar 18, 2024 | Pending |
Array
(
[id] => 20328379
[patent_doc_number] => 12458636
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-04
[patent_title] => Methods and compositions relating to steroid hormone receptor-dependent proliferative disorders
[patent_app_type] => utility
[patent_app_number] => 18/441067
[patent_app_country] => US
[patent_app_date] => 2024-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 62
[patent_no_of_words] => 16593
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18441067
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/441067 | Methods and compositions relating to steroid hormone receptor-dependent proliferative disorders | Feb 13, 2024 | Issued |
Array
(
[id] => 19096455
[patent_doc_number] => 20240115682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => METHODS OF TREATING CANCER USING HETEROARYL-BIPHENYL AMIDE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 18/509667
[patent_app_country] => US
[patent_app_date] => 2023-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11054
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18509667
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/509667 | METHODS OF TREATING CANCER USING HETEROARYL-BIPHENYL AMIDE DERIVATIVES | Nov 14, 2023 | Abandoned |
Array
(
[id] => 19232125
[patent_doc_number] => 20240189316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => DEUTERATED ANALOGS OF ETIFOXINE AND METHODS OF ADMINISTRATION WITHOUT AUTOINDUCTION OF METABOLISM
[patent_app_type] => utility
[patent_app_number] => 18/493488
[patent_app_country] => US
[patent_app_date] => 2023-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8103
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18493488
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/493488 | DEUTERATED ANALOGS OF ETIFOXINE AND METHODS OF ADMINISTRATION WITHOUT AUTOINDUCTION OF METABOLISM | Oct 23, 2023 | Pending |
Array
(
[id] => 18628125
[patent_doc_number] => 20230286954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => PYRAZOLE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 18/319066
[patent_app_country] => US
[patent_app_date] => 2023-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5835
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18319066
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/319066 | Pyrazole derivatives | May 16, 2023 | Issued |
Array
(
[id] => 18808560
[patent_doc_number] => 20230382894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => CCR4 ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 18/302041
[patent_app_country] => US
[patent_app_date] => 2023-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22810
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18302041
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/302041 | CCR4 ANTAGONISTS | Apr 17, 2023 | Pending |
Array
(
[id] => 19961583
[patent_doc_number] => 12331067
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-17
[patent_title] => Method for preparing
[patent_app_type] => utility
[patent_app_number] => 18/132479
[patent_app_country] => US
[patent_app_date] => 2023-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 956
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18132479
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/132479 | Method for preparing | Apr 9, 2023 | Issued |
Array
(
[id] => 18657639
[patent_doc_number] => 20230303568
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => INTERMEDIATE USEFUL FOR THE SYNTHESIS OF TGF-BETA INHIBITORS AND A METHOD OF PREPARING TGF-BETA INHIBITORS USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/188912
[patent_app_country] => US
[patent_app_date] => 2023-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5075
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18188912
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/188912 | Intermediate useful for the synthesis of TGF-beta inhibitors and a method of preparing TGF-beta inhibitors using the same | Mar 22, 2023 | Issued |
Array
(
[id] => 20033186
[patent_doc_number] => 20250171408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-29
[patent_title] => NOVEL SOLID STATE FORMS OF INDOXACARB
[patent_app_type] => utility
[patent_app_number] => 18/834307
[patent_app_country] => US
[patent_app_date] => 2023-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18834307
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/834307 | NOVEL SOLID STATE FORMS OF INDOXACARB | Feb 1, 2023 | Pending |
Array
(
[id] => 20364009
[patent_doc_number] => 20250353821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-11-20
[patent_title] => BENZENE SULFONAMIDE THIAZOLE COMPOUNDS AND THEIR USE FOR THE TREATMENT OF CANCERS
[patent_app_type] => utility
[patent_app_number] => 18/721781
[patent_app_country] => US
[patent_app_date] => 2022-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17500
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18721781
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/721781 | BENZENE SULFONAMIDE THIAZOLE COMPOUNDS AND THEIR USE FOR THE TREATMENT OF CANCERS | Dec 20, 2022 | Pending |
Array
(
[id] => 19752727
[patent_doc_number] => 20250041292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-06
[patent_title] => METHODS FOR TREATING PRIMARY IMMUNODEFICIENCY
[patent_app_type] => utility
[patent_app_number] => 18/717360
[patent_app_country] => US
[patent_app_date] => 2022-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28714
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18717360
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/717360 | METHODS FOR TREATING PRIMARY IMMUNODEFICIENCY | Dec 8, 2022 | Pending |
Array
(
[id] => 20425318
[patent_doc_number] => 20250387405
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-12-25
[patent_title] => PHARMACEUTICAL COMPOSITION CONTAINING PLATINUM DRUGS OR PLATINUM DRUG COCRYSTALS, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/713580
[patent_app_country] => US
[patent_app_date] => 2022-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1273
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18713580
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/713580 | PHARMACEUTICAL COMPOSITION CONTAINING PLATINUM DRUGS OR PLATINUM DRUG COCRYSTALS, AND USE THEREOF | Nov 24, 2022 | Pending |
Array
(
[id] => 18647748
[patent_doc_number] => 20230293518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => SUBSTITUTED PYRIDAZINONES FOR USE IN THE TREATMENT OF NEUROMUSCULAR DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/053332
[patent_app_country] => US
[patent_app_date] => 2022-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46310
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18053332
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/053332 | SUBSTITUTED PYRIDAZINONES FOR USE IN THE TREATMENT OF NEUROMUSCULAR DISEASES | Nov 6, 2022 | Pending |
Array
(
[id] => 19752707
[patent_doc_number] => 20250041272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-06
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING CANCER VIA PTP1B INHIBITION
[patent_app_type] => utility
[patent_app_number] => 18/706869
[patent_app_country] => US
[patent_app_date] => 2022-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19450
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18706869
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/706869 | COMPOSITIONS AND METHODS FOR TREATING CANCER VIA PTP1B INHIBITION | Nov 2, 2022 | Pending |
Array
(
[id] => 19784283
[patent_doc_number] => 20250057962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-20
[patent_title] => PROCESSABLE COMPOSITIONS AND USE FOR THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/706880
[patent_app_country] => US
[patent_app_date] => 2022-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61294
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -50
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18706880
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/706880 | PROCESSABLE COMPOSITIONS AND USE FOR THE SAME | Nov 1, 2022 | Pending |
Array
(
[id] => 18347716
[patent_doc_number] => 20230135826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => Difluoromethylene Synthons And Methods Of Use
[patent_app_type] => utility
[patent_app_number] => 18/051549
[patent_app_country] => US
[patent_app_date] => 2022-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4078
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18051549
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/051549 | Difluoromethylene Synthons And Methods Of Use | Oct 31, 2022 | Pending |
Array
(
[id] => 18321556
[patent_doc_number] => 20230119684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => MECHANOCHEMICAL DYNAMIC FOR FOCAL CANCER TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/965908
[patent_app_country] => US
[patent_app_date] => 2022-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14946
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17965908
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/965908 | Mechanochemical dynamic for focal cancer treatment | Oct 13, 2022 | Issued |